Friday December 05 2008 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

Building Biotechnology - Starting, managing, and understanding biotechnology companies' is a comprehensive resource on commercializing biotechnology. 

A book to help seasoned business professionals apply their expertise to biotechnology business development and to help entrepreneurial scientists to develop their ideas into commercially attractive products.

'Building Biotechnology - Starting, managing, and understanding biotechnology companies' is a comprehensive resource on commercializing biotechnology. The primary audience of 'Building Biotechnology' is business professionals and entrepreneurial scientists.

'Building Biotechnology' enables business professionals and entrepreneurial scientists to understand the biotechnology industry, its drivers, and opportunities and strategies for commercial success.

- Fund and assemble a company
- Manage research & development, alliances, and funding
- Understand the legal, regulatory, political, commercial, and scientific factors influencing biotechnology
- Invest intelligently in biotechnology stocks
- Cultivate a career in biotechnology with or without a Ph.D. or MBA

"A very valuable, readable, clear, comprehensive, and up to date guide of the biotechnology industry, 'Building Biotechnology' is a must read for investors, reporters, directors, and other laymen that wish to understand the fundamentals of the biotechnology industry."
- William A. Haseltine, Ph.D., Chairman and CEO, Human Genome Sciences, Inc.

'Building Biotechnology' is available at online retailers such as Amazon.com or directly from www.BuildingBiotechnology.com .

---
Yali Friedman, info@thinkbiotech.com , 716-308-7668.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2008 - BioPortfolio Limited.